EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

Needle-free vaccine technology wins $3.7m in funding from CEPI

Micron Biomedical, an Atlanta-based life sciences company, has received funding for its technology that could improve vaccine access.
Handshake on blue background

Vertex strikes deal for Orna Therapeutics' LNP technology

The deal is set to help Vertex’s development of next-generation gene editing therapies for sickle cell disease and beta-thalassemia.
Illustration of vaccine factory.

WuXi Biologics offloads Irish vaccine plant to Merck for $500m

WuXi Biologics sells its vaccine production facility in Ireland to Merck & Co for $500m in the wake of changing regulation in the US.
Gold crown on blue background

Could Eli Lilly take the crown in the obesity market?

According to a recent release from GlobalData, Eli Lilly’s obesity offering could become a potential leader in the market.
Researchers

Gene therapy from Novartis shows promise for children with SMA

Novartis’ Phase III study has demonstrated significant improvement in motor function in children and young adults with spinal muscular atrophy

Spoonful of technology: Nov-Dec 2024

Discover the latest examples of how pharma and its partners are working together to develop technology to solve key industry challenges.
The word spotlight on a blue background

Spotlight: December 2024

Catch up on all the latest pharmaceutical industry news from the past month, from breakthroughs in gene therapy to promising drug approvals and more.
stamp of approval

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.